Jul 16, 2026 09:10AM
Jul 8, 2026 03:12AM
Jun 10, 2026 05:19AM
May 26, 2026 06:51AM
May 26, 2026 06:44AM
May 20, 2026 04:06AM
May 19, 2026 03:05PM Jones Trading Upgrades Relay Therapeutics (RLAY) to Buy
May 19, 2026 06:01AM
Apr 29, 2026 07:06AM
Apr 28, 2026 05:24AM
Apr 28, 2026 04:12AM
Apr 27, 2026 04:30PM
Apr 27, 2026 10:51AM
Apr 27, 2026 06:00AM Relay announces plans for Phase 3 breast cancer trial of drug combination
Apr 23, 2026 10:21AM
Mar 23, 2026 06:46AM
Mar 20, 2026 09:48AM
Mar 17, 2026 05:20AM
Mar 16, 2026 04:37PM
Mar 13, 2026 07:59AM
Mar 3, 2026 05:08AM Relay Therapeutics (RLAY) Reiterated at Market Outperform by Citizens Before ESMO Congress
Feb 3, 2026 07:05AM
Jan 26, 2026 06:03AM
Dec 12, 2025 07:01AM
Dec 12, 2025 05:08AM
Nov 18, 2025 04:45AM
Nov 6, 2025 04:53PM
Sep 4, 2025 05:40AM Guggenheim Starts Relay Therapeutics (RLAY) at Buy, New Best Idea
Aug 8, 2025 06:26AM
Aug 7, 2025 05:21PM
Jun 11, 2025 04:07PM
Jun 3, 2025 04:27AM
Jun 2, 2025 07:02AM
May 30, 2025 05:01AM
May 5, 2025 04:10PM Relay Therapeutics, Inc. (RLAY) Tops Q1 EPS by 6c
Feb 28, 2025 04:26AM
Feb 26, 2025 05:27PM
Feb 3, 2025 04:43AM
Dec 12, 2024 06:02AM
Dec 4, 2024 06:48AM
Dec 4, 2024 06:18AM
Dec 3, 2024 08:01AM Relay Therapeutics (RLAY) and Elevar Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
Nov 6, 2024 04:44PM
Oct 14, 2024 07:22AM
Oct 1, 2024 02:55PM
Sep 16, 2024 06:55AM
Sep 16, 2024 06:45AM
Sep 11, 2024 06:17AM
Sep 10, 2024 03:17AM Jefferies Upgrades Relay Therapeutics (RLAY) to Buy
Sep 10, 2024 02:20AM

430,605 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All